Hexanoic acid derivatives designed to inhibit prolyl hydroxylase domain containing protein 2 (PHD2)

Novel hexanoic acid-based compounds designed as PHD2 inhibitors. These derivatives structurally mimic the natural co-substrate 2-oxoglutarate and are expected to coordinate ferrous iron at the enzyme's active site, offer...